Charles River demonstrates CRISPR/Cas9 genome engineering expertise
2 December 2016 | By Charles Rivers Laboratories
Charles River Laboratories has launched a full, end-to-end service offering of CRISPR/Cas9 genome engineering technology...
List view / Grid view
2 December 2016 | By Charles Rivers Laboratories
Charles River Laboratories has launched a full, end-to-end service offering of CRISPR/Cas9 genome engineering technology...
2 December 2016 | By Niamh Louise Marriott, Digital Editor
Under the terms of the licence agreement, Oxford BioMedica has granted an exclusive intellectual property licence to Orchard for collaboration programmes...
1 December 2016 | By Niamh Louise Marriott, Digital Editor
A Cancer Research UK analysis reveals that rates of mouth (oral) cancer have jumped by 68% in the UK over the last 20 years...
1 December 2016 | By Niamh Louise Marriott, Digital Editor
The funds will enable Kymab to advance its proprietary pipeline of first-in-class therapeutic human monoclonal antibodies, with clinical development in 2017...
30 November 2016 | By Niamh Louise Marriott, Digital Editor
Scientists at The Scripps Research Institute have developed a vaccine that blocks the pain-numbing effects of the opioid drugs in animal models...
30 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A study has identified the 5 genetic variants associated with higher levels of the branched-chain amino acids were associated with an increased risk...
29 November 2016 | By Niamh Louise Marriott, Digital Editor
The Research Training Groups will receive funding of around €87 million for an initial period of four and a half years...
29 November 2016 | By SMi Group
Pharmaceutical Microbiology 2017 will bring together MHRA, Paul Ehrilch Institut, Sanofi, Lonza, Steris, Pfizer and many more to explore the topics of contamination and endotoxins, quality assurance and control, environmental monitoring, new mechanisms of detection and the newly added topic of pharmaceutical water systems...
28 November 2016 | By Niamh Louise Marriott, Digital Editor
This preclinical study should explore the potential of AIC649 to cure infections caused by hepatitis B virus (HBV) and is investigating the efficacy...
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Research coordinated by Karolinska Institutet have identified a link between defective sucrase-isomaltase gene variants and irritable bowel syndrome...
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Proteros has entered into a second research agreement with Merck aimed at developing small molecule compounds against an additional epigenetic target...
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Hokkaido University researchers have developed a spinal symmetry-recognition system that can 3-dimensionally detect early stages of idiopathic scoliosis...
21 November 2016 | By Dr Nick Thompson, Holisticvet Consultancy
Holistic Vet Dr Nick Thompson explains how over use of worming treatment has lead to epidemic resistance affecting up to 40% of UK children...
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers at the University of Oxford have been working with two major EU-funded projects to deliver a novel antibiotic programme for clinical development...
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Five European research institutions have come together in recognition of the need to advance knowledge on the pathophysiology of psoriatic arthritis...